Impaired Autophagy in Crohn's Disease Linked to ATG16L1 Variant
Author Information
Author(s): Petric Kuballa, Alan Huett, John D. Rioux, Mark J. Daly, Ramnik J. Xavier
Primary Institution: Massachusetts General Hospital, Harvard Medical School
Hypothesis
The ATG16L1*300A variant is associated with impaired autophagy in Crohn's disease.
Conclusion
The ATG16L1*300A variant is less effective in mediating anti-Salmonella autophagy compared to the ATG16L1*300T variant.
Supporting Evidence
- The ATG16L1*300A variant shows impaired bacterial handling in human epithelial cells.
- Cells expressing ATG16L1*300A capture less bacteria within autophagosomes compared to those expressing ATG16L1*300T.
- Endogenous levels of ATG16L1*300T can compensate for the instability of the *300A variant.
Takeaway
Some people have a gene variant that makes it harder for their cells to fight off certain bacteria, which might be linked to Crohn's disease.
Methodology
The study used a knock-down/reconstitution strategy in human epithelial cells to assess the function of ATG16L1 variants during Salmonella infection.
Limitations
The study primarily used cell lines, which may not fully replicate the complexity of human disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website